Drug recall: Tuberculinum Bovinum due to manufacturing practice deviations
Washington Homeopathic Products is recalling Tuberculinum Bovinum homeopathic remedy due to current good manufacturing practice deviations. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary precautionary recall based on manufacturing practice deviations. No illnesses, injuries, or hospitalizations have been reported, making it a precautionary compliance action rather than a safety incident.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Tuberculinum Bovinum homeopathic remedy in potencies 12C, 30C, and 200C, distributed as liquid pellets. The recall involves Lot Numbers 19148 and 21028.
The recall was initiated due to current good manufacturing practice (cGMP) deviations. These are violations of FDA manufacturing standards that govern how drugs are produced and quality-controlled.
This product was distributed nationwide throughout the United States. No illnesses or adverse events have been reported in connection with this recall.
Consumers should consult their healthcare provider regarding any products from the affected lots.
The recalled product
- Product
- Tuberculinum Bovinum, Potency: 12C, 30C, 200C, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug
- Hazard
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 19148
- 21028
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27